Myopathy, reducing body, X-linked, early-onset, severe: genes and variants
Explore variant evidence for Myopathy, reducing body, X-linked, early-onset, severe across 1 analyzed protein (FHL1). Linked ClinVar records include 5 pathogenic or likely pathogenic variants, 5 variants of uncertain significance and 1 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Myopathy, reducing body, X-linked, early-onset, severe
FHL1: Four and a half LIM domains protein 1
It organizes protein complexes in striated muscle and participates in mechanosensing, sarcomere structure, and transcriptional responses. X-linked pathogenic variants cause a spectrum including reducing-body myopathy, Emery-Dreifuss muscular dystrophy, scapuloperoneal myopathy, and cardiomyopathy.
5 ClinVar pathogenic / likely pathogenic and 6 uncertain variants in FHL1 have source records linked to Myopathy, reducing body, X-linked, early-onset, severe. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Myopathy, reducing body, X-linked, early-onset, severe
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| FHL1 C150R | 150 | LIM zinc-binding 2 | Pathogenic / likely pathogenic (★★) |
| FHL1 C101F | 101 | LIM zinc-binding 2 | Pathogenic / likely pathogenic (★) |
| FHL1 H123Y | 123 | LIM zinc-binding 2 | Pathogenic / likely pathogenic |
| FHL1 H123L | 123 | LIM zinc-binding 2 | Pathogenic / likely pathogenic |
| FHL1 C153F | 153 | LIM zinc-binding 2 | Pathogenic / likely pathogenic |
Same protein, different disease
- X-linked myopathy with postural muscle atrophy also has ClinVar records linked to FHL1 variants; they fall partly in the same places as the Myopathy, reducing body, X-linked, early-onset, severe variants (17 pathogenic / likely pathogenic).
Diseases related to Myopathy, reducing body, X-linked, early-onset, severe
- X-linked myopathy with postural muscle atrophy, also linked to FHL1
- Emery-Dreifuss muscular dystrophy, also linked to FHL1
- Myopathy, also linked to FHL1
- Centronuclear myopathy, also linked to FHL1
- Myopathy, reducing body, X-linked, childhood-onset, also linked to FHL1
Frequently asked questions
Which genes have records linked to Myopathy, reducing body, X-linked, early-onset, severe?
This view contains 1 analyzed proteins: FHL1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 5 pathogenic or likely pathogenic variants, 5 variants of uncertain significance and 1 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 21 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center